Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 85.11B | 84.31B | 77.99B | 77.30B | 73.42B | 74.19B |
Gross Profit | 26.94B | 26.88B | 32.88B | 31.62B | 32.20B | 30.93B |
EBITDA | 24.73B | 24.51B | 23.48B | 22.11B | 22.17B | 21.42B |
Net Income | 12.69B | 12.40B | 12.13B | 10.85B | 10.66B | 10.52B |
Balance Sheet | ||||||
Total Assets | 114.59B | 118.27B | 115.57B | 119.65B | 118.61B | 112.18B |
Cash, Cash Equivalents and Short-Term Investments | 3.96B | 3.51B | 3.16B | 3.26B | 3.19B | 3.10B |
Total Debt | 8.00M | 10.00M | 43.00M | 106.00M | 198.00M | 308.00M |
Total Liabilities | 15.74B | 19.07B | 18.09B | 18.53B | 18.42B | 17.80B |
Stockholders Equity | 96.14B | 96.54B | 95.09B | 98.88B | 96.42B | 91.03B |
Cash Flow | ||||||
Free Cash Flow | 9.49B | 9.53B | 1.76B | 6.66B | 10.49B | 9.57B |
Operating Cash Flow | 15.02B | 15.09B | 11.33B | 14.64B | 18.77B | 19.07B |
Investing Cash Flow | -3.11B | -3.57B | 4.91B | -3.94B | -13.82B | -13.11B |
Financing Cash Flow | -11.27B | -11.17B | -16.35B | -10.63B | -4.85B | -6.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | €241.81B | 19.16 | 13.98% | 2.41% | 7.33% | 10.59% | |
60 Neutral | $46.60B | 4.08 | -11.40% | 4.13% | 1.85% | -42.71% | |
― | $2.70B | 24.87 | 19.00% | 1.58% | ― | ― | |
― | $3.35B | 23.82 | 15.20% | 1.22% | ― | ― | |
― | $64.82B | 15.33 | 13.28% | 4.26% | ― | ― | |
― | $92.16B | 13.26 | 10.39% | 3.38% | ― | ― | |
69 Neutral | ¥10.85T | 21.61 | 3.78% | 7.71% | -1.03% |